User:Jssteil/sandbox/pharm refs

-Abraham, S, CY Lin, HP Klein, C Volkmann, RA Tigranyan, and EG Vetrova (1980) Studies of specific hepatic enzymes involved in the conversion of carbohydrates to lipids in rats exposed to prolonged spaceflight aboard Cosmos 1129. Physiologist 23(Suppl 6): S55-8.

-Adey, WR (1972) Studies on weightlessness in a primate in the Biosatellite 3 experiment. Life Sci Space Res 10: 67-85.

-Agency for Healthcare Research and Quality, UDoHaHS (2006) Medical Expenditure Panel Survey Component Data.

-Allebban, Z, LA Gibson, RD Lange, TL Jago, KM Strickland, DL Johnson, and AT Ichiki (1996) Effects of spaceflight on rat erythroid parameters. J Appl Physiol 81(1): 117-22.

-Ameer, B, M Divoll, DR Abernethy, DJ Greenblatt, and L Shargel (1983) Absolute and relative bioavailability of oral acetaminophen preparations. J Pharm Sci 72(8): 955-8.

-Andrews, PL, F Okada, AJ Woods, H Hagiwara, S Kakaimoto, M Toyoda, and N Matsuki (2000) The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew. Br J Pharmacol 130(6): 1247-54.

-Anken, RH, and R Hilbig (2004) A drop-tower experiment to determine the threshold of gravity for inducing motion sickness in fish. Adv Space Res 34(7): 1592-7.

-Arendt, J, M Aldhous, and V Marks (1986) Alleviation of jet lag by melatonin: preliminary results of controlled double blind trial. Br Med J (Clin Res Ed) 292(6529): 1170.

-Arendt, J, and V Marks (1986) Jet lag and melatonin. Lancet 2(8508): 698-9.

-Bagian, JP, and DF Ward (1994) A retrospective study of promethazine and its failure to produce the expected incidence of sedation during space flight. J Clin Pharmacol 34(6): 649-51.

-Bai, YD, FS Yang, K Xuan, YX Bai, and BL Wu (2008) Inhibition of RANK/RANKL signal transduction pathway: a promising approach for osteoporosis treatment. Med Hypotheses 71(2): 256-8.

-Balaban, E, C Centini, and O Pompeiano (2002) Tonic gravity changes alter gene expression in the efferent vestibular nucleus. Neuroreport 13(1): 187-90.

-Banks, S, and DF Dinges (2007) Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med 3(5): 519-28.

-Banta, GR, WC Ridley, J McHugh, JD Grissett, and FE Guedry (1987) Aerobic fitness and susceptibility to motion sickness. Aviat Space Environ Med 58(2): 105-8.

-Baqai, FP, DS Gridley, JM Slater, X Luo-Owen, LS Stodieck, V Ferguson, SK Chapes, and MJ Pecaut (2009) Effects of spaceflight on innate immune function and antioxidant gene expression. J Appl Physiol 106(6): 1935-42.

-Barbarin, N, B Tilquin, and E de Hoffmann (2001) Radiosterilization of cefotaxime: investigation of potential degradation compounds by liquid chromatography-electrospray mass spectrometry. J Chromatogr A 929(1-2): 51-61.

-Basner, M, J Rubinstein, KM Fomberstein, MC Coble, A Ecker, D Avinash, and DF Dinges (2008) Effects of night work, sleep loss and time on task on simulated threat detection performance. Sleep 31(9): 1251-9.

-Bayorh, MA, RR Socci, S Watts, M Wang, D Eatman, N Emmett, and M Thierry-Palmer (2001) L-NAME, a nitric oxide synthase inhibitor, as a potential countermeasure to post-suspension hypotension in rats. Clin Exp Hypertens 23(8): 611-22.

-Beaumont, M, D Batejat, C Pierard, P Van Beers, M Philippe, D Leger, G Savourey, and JC Jouanin (2007) Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude. Sleep 30(11): 1527-33.

-Becker, PM, and M Sattar (2009) Treatment of sleep dysfunction and psychiatric disorders. Curr Treat Options Neurol 11(5): 349-57.

-Ben-Zvi, Z, E Gussarsky, C van Creveld, and R Yagil (1996) The bioavailability of febantel in dehydrated camels. J Vet Pharmacol Ther 19(4): 288-94.

-Berlin, I, D Warot, T Hergueta, P Molinier, C Bagot, and AJ Puech (1993) Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects. J Clin Psychopharmacol 13(2): 100-6.

-Bernardini, AT, and M Taub (1969) Effects of reduced pressure and drug administration on the glucose tolerance test in the dog. Aerosp Med 40(4): 409-12.

-Berne, R, and M Levy (1988). Physiology. St Louis, Mosby.

-Bhasin, S, OM Calof, TW Storer, ML Lee, NA Mazer, R Jasuja, VM Montori, W Gao, and JT Dalton (2006) Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2(3): 146-59.

-Bhasin, S, and R Jasuja (2009) Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care 12(3): 232-40.

-Bhasin, S, TW Storer, N Berman, C Callegari, B Clevenger, J Phillips, TJ Bunnell, R Tricker, A Shirazi, and R Casaburi (1996) The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335(1): 1-7.

-Bhasin, S, TW Storer, N Berman, KE Yarasheski, B Clevenger, J Phillips, WP Lee, TJ Bunnell, and R Casaburi (1997) Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 82(2): 407-13.

-Bhasin, S, L Woodhouse, R Casaburi, AB Singh, D Bhasin, N Berman, X Chen, KE Yarasheski, L Magliano, C Dzekov, J Dzekov, R Bross, J Phillips, I Sinha-Hikim, R Shen, and TW Storer (2001) Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281(6): E1172-81.

-Bhasin, S, L Woodhouse, R Casaburi, AB Singh, RP Mac, M Lee, KE Yarasheski, I Sinha-Hikim, C Dzekov, J Dzekov, L Magliano, and TW Storer (2005) Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90(2): 678-88.

-Bhatia, AL, and K Manda (2004) Study on pretreatment of melatonin against radiation -induced oxidative stress in mice. Environmental Toxicology and Pharmacology 18: 13-20.

-Bhatia, AL, A Sharma, S Patni, and AL Sharma (2007) Prophylactic effect of flaxseed oil against radiation- induced hepatotoxicity in mice. Phytother Res 21(9): 852-9.

-Bilska, A, and L Wlodek (2005) Lipoic acid - the drug of the future? Pharmacol Rep 57(5): 570-7.

-Black, DM, DE Thompson, DC Bauer, K Ensrud, T Musliner, MC Hochberg, MC Nevitt, S Suryawanshi, and SR Cummings (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85(11): 4118-24.

-Bles, W, B de Graaf, JE Bos, E Groen, and JR Krol (1997) A sustained hyper-g load as a tool to simulate space sickness. J Gravit Physiol 4(2): P1-4.

Bloodgood, RA. (2003). "Histology of the Inner Ear." from http://www.med-ed.virginia.edu/public/CourseSitesDocs/CellandTissueStructure/handouts/unrestricted/original/ MMHndt_Ear.html.

-Bonnet, MH, TJ Balkin, DF Dinges, T Roehrs, NL Rogers, and NJ Wesensten (2005) The use of stimulants to modify performance during sleep loss: a review by the sleep deprivation and Stimulant Task Force of the American Academy of Sleep Medicine. Sleep 28(9): 1163-87.

-Borison, HL (1983) A 1983 neuropharmacologic perspective of space sickness. Brain Behav Evol 23(1-2): 7-13.

-Bos, JE, W Bles, and B de Graaf (2002) Eye movements to yaw, pitch, and roll about vertical and horizontal axes: adaptation and motion sickness. Aviat Space Environ Med 73(5): 436-44.

-Boyce, BF, L Xing, W Shakespeare, Y Wang, D Dalgarno, J Iuliucci, and T Sawyer (2003) Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases. Kidney Int Suppl(85): S2-5.

-Boyd, JL, B Du, Z Vaksman, JP Locke, and L Putcha (2007) Relative bioavailability of scopolamine dosage forms and interaction with dextroamphetamine. J Gravit Physiol 14(1): P107-8.

-Boyum, A, P Wiik, E Gustavsson, OP Veiby, J Reseland, AH Haugen, and PK Opstad (1996) The effect of strenuous exercise, calorie deficiency and sleep deprivation on white blood cells, plasma immunoglobulins and cytokines. Scand J Immunol 43(2): 228-35.

-Brixen, KT, PM Christensen, C Ejersted, and BL Langdahl (2004) Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis. Basic Clin Pharmacol Toxicol 94(6): 260-70.

-Broskey, J, and MK Sharp (2007) Evaluation of mechanisms of postflight orthostatic intolerance with a simple cardiovascular system model. Ann Biomed Eng 35(10): 1800-11.

-Brown, TE, and DL Eckberg (1997) Promethazine affects autonomic cardiovascular mechanisms minimally. J Pharmacol Exp Ther 282(2): 839-44.

-Brunner, LJ, S Bai, and H Abdus-Salaam (2000) Effect of simulated weightlessness on phase II drug metabolism in the rat. Aviat Space Environ Med 71(9): 899-903.

-Brunner, LJ, JT DiPiro, and S Feldman (1995) Antipyrine pharmacokinetics in the tail-suspended rat model. J Pharmacol Exp Ther 274(1): 345-52.

-Buckey, JC (2006). Space Physiology. New York, Oxford.

-Buckey, JC, D Alvarenga, B Cole, and JR Rigas (2004) Chlorpheniramine for motion sickness. J Vestib Res 14(1): 53-61.

-Buckey, JC, Jr., LD Lane, BD Levine, DE Watenpaugh, SJ Wright, WE Moore, FA Gaffney, and CG Blomqvist (1996) Orthostatic intolerance after spaceflight. J Appl Physiol 81(1): 7-18.

-Bungo, MW, JB Charles, and PC Johnson, Jr. (1985) Cardiovascular deconditioning during space flight and the use of saline as a countermeasure to orthostatic intolerance. Aviat Space Environ Med 56(10): 985-90.

-Bustin, SA (2010) Why the need for qPCR publication guidelines?--The case for MIQE. Methods 50(4): 217-26.

-Bustin, SA, V Benes, JA Garson, J Hellemans, J Huggett, M Kubista, R Mueller, T Nolan, MW Pfaffl, GL Shipley, J Vandesompele, and CT Wittwer (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4): 611-22.

-Caldwell, JA, NK Smythe, PA Leduc, and JL Caldwell (2000) Efficacy of Dexedrine for maintaining aviator performance during 64 hours of sustained wakefulness: a simulator study. Aviat Space Environ Med 71(1): 7-18.

-Carcenac, C, S Herbute, C Masseguin, L Mani-Ponset, D Maurel, R Briggs, A Guell, and JB Gabrion (1999) Hindlimb-suspension and spaceflight both alter cGMP levels in rat choroid plexus. J Gravit Physiol 6(2): 17-24.

-Casaburi, R, S Bhasin, L Cosentino, J Porszasz, A Somfay, MI Lewis, M Fournier, and TW Storer (2004) Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170(8): 870-8.

-Cavanagh, PR, AA Licata, and AJ Rice (2005) Exercise and pharmacological countermeasures for bone loss during long-duration space flight. Gravit Space Biol Bull 18(2): 39-58.

-Charles, JB, and MW Bungo (1991) Cardiovascular physiology in space flight. Exp Gerontol 26(2-3): 163- 8.

-Chen, J, J Kim, and JT Dalton (2005) Discovery and therapeutic promise of selective androgen receptor modulators. Mol Interv 5(3): 173-88.

-Chi, MM, R Choksi, P Nemeth, I Krasnov, E Ilyina-Kakueva, JK Manchester, and OH Lowry (1992) Effects of microgravity and tail suspension on enzymes of individual soleus and tibialis anterior fibers. J Appl Physiol 73(2 Suppl): 66S-73S.

-Cho, K, A Ennaceur, JC Cole, and CK Suh (2000) Chronic jet lag produces cognitive deficits. J Neurosci 20(6): RC66.

-Cho, MM, NP Ziats, FW Abdul-Karim, D Pal, J Goldfarb, WH Utian, and GI Gorodeski (1998) Effects of estrogen on tight junctional resistance in cultured human umbilical vein endothelial cells. J Soc Gynecol Investig 5(5): 260-70.

-Chowdhury, P, ME Soulsby, and JN Pasley (1999) Distribution of 3H-nicotine in rat tissues under the influence of simulated microgravity. Biomed Environ Sci 12(2): 103-9.

-Chowdhury, P, M Soulsby, K Kim (2007) L-Caritine influence on oxidative stress induced by hind limb unloading in adult rats. Aviat Space Environ Med 78(6):554-6.

-Cintron, NM, HW Lane, and CS Leach (1990) Metabolic consequences of fluid shifts induced by microgravity. Physiologist 33(1 Suppl): S16-9.

-Cintron, NM, L Putcha, Y-M Chen, and JM Vanderploeg (1987b). In-flight salivary pharmacokinetics of scopalamine and dextramphetamine. NASA Technical Memorandum 58280. Houston, NASA: 25- 29.

-Cintron, NM, L Putcha, and JM Vanderploeg (1987a). In-flight pharmacokinetics of acetaminophen in saliva. NASA Technical Memorandum 58280. Houston, NASA: 19-23.

-Clement, G (2003). Fundamentals of Space Medicine. El Segundo, CA, Microcosm and Kluwer.

-Clements, JA, RC Heading, WS Nimmo, and LF Prescott (1978) Kinetics of acetaminophen absorption and gastric emptying in man. Clin Pharmacol Ther 24(4): 420-31.

-Clissold, SP, and RC Heel (1985) Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29(3): 189-207.

-Cohen, B, M Dai, SB Yakushin, and T Raphan (2008) Baclofen, motion sickness susceptibility and the neural basis for velocity storage. Prog Brain Res 171: 543-53.

-Coleman, CN, HB Stone, JE Moulder, and TC Pellmar (2004) Medicine. Modulation of radiation injury. Science 304(5671): 693-4.

-Coleman, PJ, and JJ Renger (2010) Orexin receptor antagonists: a review of promising compounds patented since 2006. Expert Opin Ther Pat 20(3): 307-24.

-Conder, GA, HS Sedlacek, JF Boucher, and RG Clemence (2008) Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs. J Vet Pharmacol Ther 31(6): 528-32.

-Connolly, J, J Boulter, and SF Heinemann (1992) Alpha 4-2 beta 2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br J Pharmacol 105(3): 657-66.

-Convertino, VA, DA Ludwig, BD Gray, and J Vernikos (1998) Effects of exposure to simulated microgravity on neuronal catecholamine release and blood pressure responses to norepinephrine and angiotensin. Clin Auton Res 8(2): 101-10.

-Cowings, P, C Stout, W Toscano, S Reynoso, C DeRoshia, and N Miller (1996) The Effects of Promethazine on Human Performance, Mood States and Motion Sickness ToleranceThe Effects of Promethazine on Human Performance, Mood States and Motion Sickness Tolerance. NASA Technical Memorandum 110420.

-Cowings, PS, and WB Toscano (2000) Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms. J Clin Pharmacol 40(10): 1154-65.

-Cowings, PS, WB Toscano, C DeRoshia, and NE Miller (2000) Promethazine as a motion sickness treatment: impact on human performance and mood states. Aviat Space Environ Med 71(10): 1013-22.

-Cramer, JA, RH Mattson, ML Prevey, RD Scheyer, and VL Ouellette (1989) How often is medication taken as prescribed? A novel assessment technique. JAMA 261(22): 3273-7.

-Crampton, GH, and JB Lucot (1985) A stimulator for laboratory studies of motion sickness in cats. Aviat Space Environ Med 56(5): 462-5.

-Crema, A, GM Frigo, and S Lecchini (1970) A pharmacological analysis of the peristaltic reflex in the isolated colon of the guinea-pig or cat. Br J Pharmacol 39(2): 334-45.

-Crucian, B (2009). Risk of Crew Adverce Health Event Due to Altered Immune Response. H NASA, HHC.

-Crucq, AS, and B Tilquin (1996) Method to identify products induced by radiosterilization. A study of cefotaxime sodium. J Pharm Belg 51(6): 285-8.

-Cucinotta, FA, and M Durante (2008). Risk of Radiation Carcinogenesis. H NASA, HHC.

-Cucinotta, FA, H Wang, and J Huff (2008). Risk of Acute or Late Central Nervous System Effects from Radiation Exposure. H NASA, HHC.

-Cummings, SR, DM Black, DE Thompson, WB Applegate, E Barrett-Connor, TA Musliner, L Palermo, R Prineas, SM Rubin, JC Scott, T Vogt, R Wallace, AJ Yates, and AZ LaCroix (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280(24): 2077-82.

-Czarnik, TR, and J Vernikos (1999) Physiological changes in spaceflight that may affect drug action. J Gravit Physiol 6(1): P161-4.

-D'Aunno, DS, AH Dougherty, HF DeBlock, and JV Meck (2003) Effect of short- and long-duration spaceflight on QTc intervals in healthy astronauts. Am J Cardiol 91(4): 494-7.

-da Silva, VC, PL Bittencourt, S Pinho, AR Cavalcanti, and CC Zollinger (2008) Delayed-onset hepatic encephalopathy induced by zolpidem: a case report. Clinics (Sao Paulo) 63(4): 565-6.

-Dalton, JT, A Mukherjee, Z Zhu, L Kirkovsky, and DD Miller (1998) Discovery of nonsteroidal androgens. Biochem Biophys Res Commun 244(1): 1-4.

-Danjou, P, I Paty, R Fruncillo, P Worthington, M Unruh, W Cevallos, and P Martin (1999) A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. Br J Clin Pharmacol 48(3): 367-74.

-Davis, JR, RT Jennings, and BG Beck (1993) Comparison of treatment strategies for Space Motion Sickness. Acta Astronaut 29(8): 587-91.

-Davis, JR, RT Jennings, BG Beck, and JP Bagian (1993) Treatment efficacy of intramuscular promethazine for space motion sickness. Aviat Space Environ Med 64(3 Pt 1): 230-3.

-Davis, JR, JM Vanderploeg, PA Santy, RT Jennings, and DF Stewart (1988) Space motion sickness during 24 flights of the space shuttle. Aviat Space Environ Med 59(12): 1185-9.

-Davrath, LR, RW Gotshall, A Tucker, WZ Sadeh, GJ Luckasen, TR Downes, and CC Coonts (1999) Moderate sodium restriction does not alter lower body negative pressure tolerance. Aviat Space Environ Med 70(6): 577-82.

-Debuys, L, and A Henrique (1918) Effect of body posture on the position and emptying time of the stomach. Am J Dis Child 15: 190.

-Descamps, A, C Rousset, MJ Millan, M Spedding, P Delagrange, and R Cespuglio (2009) Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture. Psychopharmacology (Berl) 205(1): 93-106.

-Diamond, SG, and CH Markham (1991) Otolith function in hypo- and hypergravity: relation to space motion sickness. Acta Otolaryngol Suppl 481: 19-22.

-Diedrich, A, SY Paranjape, and D Robertson (2007) Plasma and blood volume in space. Am J Med Sci 334(1): 80-5.

-Dijk, DJ, DF Neri, JK Wyatt, JM Ronda, E Riel, A Ritz-De Cecco, RJ Hughes, AR Elliott, GK Prisk, JB West, and CA Czeisler (2001) Sleep, performance, circadian rhythms, and light-dark cycles during two space shuttle flights. Am J Physiol Regul Integr Comp Physiol 281(5): R1647-64.

-Dinges, DF (2001) Sleep in space flight: breath easy--sleep less? Am J Respir Crit Care Med 164(3): 337-8.

-Dinges, DF, S Arora, M Darwish, and GE Niebler (2006) Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss. Curr Med Res Opin 22(1): 159-67.

-Dinges, DF, SD Douglas, L Zaugg, DE Campbell, JM McMann, WG Whitehouse, EC Orne, SC Kapoor, E Icaza, and MT Orne (1994) Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest 93(5): 1930-9.

-Discipline, JM (2008). Risk of Impaired Performance Due to Reduced Muscle Mass, Strength and Endurance. H NASA, HHC.

-Dressman, JB, P Bass, WA Ritschel, DR Friend, A Rubinstein, and E Ziv (1993) Gastrointestinal parameters that influence oral medications. J Pharm Sci 82(9): 857-72.

-Drummer, C, R Gerzer, F Baisch, and M Heer (2000) Body fluid regulation in micro-gravity differs from that on Earth: an overview. Pflugers Arch 441(2-3 Suppl): R66-72.

-Drummer, C, M Heer, RA Dressendörfer, CJ Strasburger, and R Gerzer (1993) Reduced natriuresis during weightlessness. Clinical Investigator 71: 678-86.

-Drummer, C, C Hesse, F Baisch, P Norsk, B Elmann-Larsen, R Gerzer, and M Heer (2000) Water and sodium balances and their relation to body mass changes in microgravity. European Journal of Clinical Investigation 30(12): 1066-75.

-Drummer, C, P Norsk, and M Heer (2001) Water and sodium balance in space. Am J Kidney Dis 38(3): 684-90.

-Drummond, SP, A Bischoff-Grethe, DF Dinges, L Ayalon, SC Mednick, and MJ Meloy (2005) The neural basis of the psychomotor vigilance task. Sleep 28(9): 1059-68.

-Du, B, V Daniels, Z Vaksman, J Boyd, C Crady, L Putcha (2011) Evaluation of physical and chemical changes in pharmaceuticals flown on space missions. AAPS J 13:299-308.

-Edwards, JP, SJ West, CL Pooley, KB Marschke, LJ Farmer, and TK Jones (1998) New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone. Bioorg Med Chem Lett 8(7): 745-50.

-Elliott, AR, SA Shea, DJ Dijk, JK Wyatt, E Riel, DF Neri, CA Czeisler, JB West, and GK Prisk (2001) Microgravity reduces sleep-disordered breathing in humans. Am J Respir Crit Care Med 164(3): 478-85.

-Elsheikh, HA, AM Osman Intisar, IB Eltayeb, and A Salam Abdullah (1998) Effect of dehydration on the pharmacokinetics of oxytetracycline hydrochloride administered intravenously in goats (Capra hircus). Gen Pharmacol 31(3): 455-8.

-Erman, M, D Seiden, G Zammit, S Sainati, and J Zhang (2006) An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med 7(1): 17-24.

-Faugloire, E, CT Bonnet, MA Riley, BG Bardy, and TA Stoffregen (2007) Motion sickness, body movement, and claustrophobia during passive restraint. Exp Brain Res 177(4): 520-32.

-FDA (2008). FDA-Approved Manufacturer Drug Insert: Drug Specific Medication Guides. NDA 19908 FDA SLR 027 Approved labeling 4.23.08 http://www.fda.gov/downloads/Drugs/DrugSafety/ucm085906.pdf. FDA.

-FDA. (2010). "Midodrine hydrochloride: FDA Proposes Withdrawal of Low Blood Pressure Drug", from http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm222640.htm.

-Fernandez, C, and JR Lindsay (1964) The Vestibular Coriolis Reaction. Arch Otolaryngol 80: 469-72.

-Ferraro, L, T Antonelli, WT O'Connor, S Tanganelli, FA Rambert, and K Fuxe (1997) Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry 42(12): 1181-3.

-Fleisher, D, C Li, Y Zhou, LH Pao, and A Karim (1999) Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications. Clin Pharmacokinet 36(3): 233- 54.

-Folkard, S, J Arendt, M Aldhous, and H Kennett (1990) Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms. Neurosci Lett 113(2): 193-8.

-Frey, MA, J Riddle, JB Charles, and MW Bungo (1991) Blood and urine responses to ingesting fluids of various salt and glucose concentrations. J Clin Pharmacol 31(10): 880-7.

-Fritsch-Yelle, JM, UA Leuenberger, DS D'Aunno, AC Rossum, TE Brown, ML Wood, ME Josephson, and AL Goldberger (1998) An episode of ventricular tachycardia during long-duration spaceflight. Am J Cardiol 81(11): 1391-2.

-Frost, JD, Jr., WH Shumate, CR Booher, and MR DeLucchi (1975) The Skylab sleep monitoring experiment: methodology and initial results. Acta Astronaut 2(3-4): 319-36.

-Fucci, RL, J Gardner, JP Hanifin, S Jasser, B Byrne, E Gerner, M Rollag, and GC Brainard (2005) Toward optimizing lighting as a countermeasure to sleep and circadian disruption in space flight. Acta Astronaut 56(9-12): 1017-24.

-Fusco, V, A Baraldi, A Loidoris, L Ciuffreda, C Galassi, F Goia, M Scoletta, S Berrone, A Benech, C Ortega, and A Berruti (2009) Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures? J Oral Maxillofac Surg 67(8): 1775.

-Gandia, P, MP Bareille, S Saivin, AP Le-Traon, M Lavit, A Guell, and G Houin (2003) Influence of simulated weightlessness on the oral pharmacokinetics of acetaminophen as a gastric emptying probe in man: a plasma and a saliva study. J Clin Pharmacol 43(11): 1235-43.

-Gandia, P, S Saivin, and G Houin (2005) The influence of weightlessness on pharmacokinetics. Fundam Clin Pharmacol 19(6): 625-36.

-Gardner, CJ, DR Armour, DT Beattie, JD Gale, AB Hawcock, GJ Kilpatrick, DJ Twissell, and P Ward (1996) GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity. Regul Pept 65(1): 45-53.

-Gauer, OH, and JP Henry (1963) Circulatory basis of fluid volume control. Physiological Reviews 43: 423- 481.

-Germain, A, DJ Buysse, and E Nofzinger (2008) Sleep-specific mechanisms underlying posttraumatic stress disorder: integrative review and neurobiological hypotheses. Sleep Med Rev 12(3): 185- 95.

-Gilman, A, TW Rall, AS Nies, and P Taylor, Eds. (1990). The Pharmacological Basis of Therapeutics. New York, Pergamon Press.

-Gisolf, J, RV Immink, JJ van Lieshout, WJ Stok, and JM Karemaker (2005) Orthostatic blood pressure control before and after spaceflight, determined by time-domain baroreflex method. J Appl Physiol 98(5): 1682-90.

-Gopalakrishnan, R, KO Genc, AJ Rice, SM Lee, HJ Evans, CC Maender, H Ilaslan, and PR Cavanagh (2010) Muscle volume, strength, endurance, and exercise loads during 6-month missions in space. Aviat Space Environ Med 81(2): 91-102.

-Grady, S, D Aeschbach, KP Wright, Jr., and CA Czeisler (2010) Effect of modafinil on impairments in neurobehavioral performance and learning associated with extended wakefulness and circadian misalignment. Neuropsychopharmacology 35(9): 1910-20.

-Graybiel, A (1976) The prevention of motion sickness in orbital flight. Life Sci Space Res 14: 109-18. Graybiel, A, and J Knepton (1976) Sopite syndrome: a sometimes sole manifestation of motion sickness. Aviat Space Environ Med 47(8): 873-82.

-Graybiel, A, CD Wood, J Knepton, JP Hoche, and GF Perkins (1975) Human assay of antimotion sickness drugs. Aviat Space Environ Med 46(9): 1107-18.

-Greenacre, SA, and H Ischiropoulos (2001) Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res 34(6): 541-81.

-Greenblatt, DJ, JS Harmatz, LL von Moltke, BL Ehrenberg, L Harrel, K Corbett, M Counihan, JA Graf, M Darwish, P Mertzanis, PT Martin, WH Cevallos, and RI Shader (1998) Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. Clin Pharmacol Ther 64(5): 553-61.

-Greenblatt, DJ, LL von Moltke, JS Harmatz, P Mertzanis, JA Graf, AL Durol, M Counihan, B Roth- Schechter, and RI Shader (1998) Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole. Clin Pharmacol Ther 64(6): 661-71.

-Grundy, D, K Reid, FJ McArdle, BH Brown, DC Barber, CF Deacon, and IW Henderson (1991) Trans- thoracic fluid shifts and endocrine responses to 6 degrees head-down tilt. Aviat Space Environ Med 62(10): 923-9.

-Gundel, A, V Nalishiti, E Reucher, M Vejvoda, and J Zulley (1993) Sleep and circadian rhythm during a short space mission. Clin Investig 71(9): 718-24.

-Gundel, A, VV Polyakov, and J Zulley (1997) The alteration of human sleep and circadian rhythms during spaceflight. J Sleep Res 6(1): 1-8.

-Guyton, A, and J Hall (2006). Textbook of Medical Physiology. Philadelphia, Elsevier Saunders.

-Hajjar, RR, FE Kaiser, and JE Morley (1997) Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 82(11): 3793-6.

-Hardeland, R, B Poeggeler, V Srinivasan, I Trakht, SR Pandi-Perumal, and DP Cardinali (2008) Melatonergic drugs in clinical practice. Arzneimittelforschung 58(1): 1-10.

-Hargens, AR, and S Richardson (2009) Cardiovascular adaptations, fluid shifts, and countermeasures related to space flight. Respir Physiol Neurobiol 169 Suppl 1: S30-3.

-Hargens, AR, and DE Watenpaugh (1996) Cardiovascular adaptation to spaceflight. Med Sci Sports Exerc 28(8): 977-82.

-Hargrove, JL, and DP Jones (1985) Hepatic enzyme adaptation in rats after space flight. Physiologist 28(6 Suppl): S230.

-Harm, DL, DE Parker, MF Reschke, and NC Skinner (1998) Relationship between selected orientation rest frame, circular vection and space motion sickness. Brain Res Bull 47(5): 497-501.

-Heaney, RP, AJ Yates, and AC Santora, 2nd (1997) Bisphosphonate effects and the bone remodeling transient. J Bone Miner Res 12(8): 1143-51.

-Heer, M, and WH Paloski (2006) Space motion sickness: incidence, etiology, and countermeasures. Auton Neurosci 129(1-2): 77-9.

-Heggie, RM, and IR Entwistle (1968) Seasickness. Br Med J 4(5629): 514.

-Henriksen, L, and P Sejrsen (1976) Local reflex in microcirculation in human cutaneous tissue. Acta Physiol Scand 98(2): 227-31.

-Herault, S, N Tobal, H Normand, J Roumy, P Denise, and P Arbeille (2002) Effect of human head flexion on the control of peripheral blood flow in microgravity and in 1 g. Eur J Appl Physiol 87(3): 296- 303.

-Herdman, SJ (1990) Treatment of benign paroxysmal positional vertigo. Phys Ther 70(6): 381-8.

-Hershkovitz, D, N Asna, A Shupak, G Kaminski, R Bar, and D Tal (2009) Ondansetron for the prevention of seasickness in susceptible sailors: an evaluation at sea. Aviat Space Environ Med 80(7): 643-6.

-Hildebrandt, W, HC Gunga, J Herrmann, L Rocker, K Kirsch, and J Stegemann (1994) Enhanced slow caudad fluid shifts in orthostatic intolerance after 24-h bed-rest. Eur J Appl Physiol Occup Physiol 69(1): 61-70.

-Hindmarch, I, and DB Fairweather (1994) Assessing the residual effects of hypnotics. Acta Psychiatr Belg 94(2): 88-95.

-Hindmarch, I, S Johnson, R Meadows, T Kirkpatrick, and Z Shamsi (2001) The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare. Curr Med Res Opin 17(4): 241-55.

-Hindmarch, I, A Patat, N Stanley, I Paty, and U Rigney (2001) Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening. Hum Psychopharmacol 16(2): 159-167.

-Hindmarch, I, U Rigney, N Stanley, P Quinlan, J Rycroft, and J Lane (2000) A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology (Berl) 149(3): 203-16.

-Hoffman, RB, GA Salinas, and JL Homick (1980) Piracetam and fish orientation during parabolic aircraft flight. Aviat Space Environ Med 51(6): 568-76.

-Hollander, J, M Gore, R Fiebig, R Mazzeo, S Ohishi, H Ohno, and LL Ji (1998) Spaceflight downregulates antioxidant defense systems in rat liver. Free Radic Biol Med 24(2): 385-90.

-Hong, MH, H Sun, CH Jin, M Chapman, J Hu, W Chang, K Burnett, J Rosen, A Negro-Vilar, and JN Miner (2008) Cell-specific activation of the human skeletal alpha-actin by androgens. Endocrinology 149(3): 1103-12.

-Horn, CC (2007) Is there a need to identify new anti-emetic drugs? Drug Discov Today Ther Strateg 4(3): 183-187.

-Hornby, PJ (2001) Central neurocircuitry associated with emesis. Am J Med 111 Suppl 8A: 106S-112S.

-Howland, J, DJ Rohsenow, S Minsky, J Snoberg, S Tagerud, SK Hunt, A Almeida, J Greece, and D Allensworth-Davies (2008) The effects of transdermal scopolamine on simulated ship navigation and attention/reaction time. Int J Occup Environ Health 14(4): 250-6.

-Hoyt, RE, BD Lawson, HA McGee, ML Strompolis, and MA McClellan (2009) Modafinil as a potential motion sickness countermeasure. Aviat Space Environ Med 80(8): 709-15.

-Hu, S, WF Grant, RM Stern, and KL Koch (1991) Motion sickness severity and physiological correlates during repeated exposures to a rotating optokinetic drum. Aviat Space Environ Med 62(4): 308- 14.

-Huff, J, and FA Cucinotta (2008). Risk of Degenerative Tissue or other Health Effects from Radiation Exposure. H NASA, HHC.

-Hunter, P (2008) To sleep, perchance to live. Sleeping is vital for health, cognitive function, memory and long life. EMBO Rep 9(11): 1070-3.

-Ikuzawa, M, and M Asashima (2008) Global expression of simulated microgravity-responsive genes in Xenopus liver cells. Zoolog Sci 25(8): 828-37.

-Ito, K, Y Kagaya, and H Shimokawa Thyroid hormone and chronically unloaded hearts. Vascul Pharmacol 52(3-4): 138-41.

-Janowsky, DS, SC Risch, M Ziegler, B Kennedy, and L Huey (1984) A cholinomimetic model of motion sickness and space adaptation syndrome. Aviat Space Environ Med 55(8): 692-6.

-Jennings, RT, JR Davis, and PA Santy (1988) Comparison of aerobic fitness and space motion sickness during the shuttle program. Aviat Space Environ Med 59(5): 448-51.

-Jiang, B, RR Roy, C Navarro, and VR Edgerton (1993) Absence of a growth hormone effect on rat soleus atrophy during a 4-day spaceflight. J Appl Physiol 74(2): 527-31.

-Jiang, Y, JJ Zhao, BH Mitlak, O Wang, HK Genant, and EF Eriksen (2003) Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18(11): 1932-41.

-Jo, SH, HK Hong, SH Chong, HS Lee, and H Choe (2009) H(1) antihistamine drug promethazine directly blocks hERG K(+) channel. Pharmacol Res 60(5): 429-37.

-Johansen, KL, K Mulligan, and M Schambelan (1999) Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA 281(14): 1275-81.

-Johansen, LB, C Gharib, AM Allevard, D Sigaudo, NJ Christensen, C Drummer, and P Norsk (1997) Haematocrit, plasma volume and noradrenaline in humans during simulated weightlessness for 42 days. Clin Physiol 17(2): 203-10.

-Juergensmeyer, MA, EA Juergensmeyer, and JA Guikema (1999) Long-term exposure to spaceflight conditions affects bacterial response to antibiotics. Microgravity Sci Technol 12(1): 41-7.

-Kacena, MA, and P Todd (2000) Gentamicin: Effect on E coli in Space. Microgravity Sci Technol XII(3-4): 135-137.

-Kakemi, K, H Sezaki, M Hayashi, and T Nadai (1968) Absorption and excretion of drugs. XXXVII. Effect of Ca2+ on the absorption of tetracycline from the small intestine. (2). Chem Pharm Bull (Tokyo) 16(11): 2206-12.

-Kakemi, K, H Sezaki, H Ogata, and T Nadai (1968) Absorption and excretion of drugs. XXXVI. Effect of Ca2+ on the absorption of tetracycline from the small intestine. (1). Chem Pharm Bull (Tokyo) 16(11): 2200-5.

-Karbownik, M, and RJ Reiter (2000) Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 225(1): 9-22.

-Karni, A, D Tanne, BS Rubenstein, JJ Askenasy, and D Sagi (1994) Dependence on REM sleep of overnight improvement of a perceptual skill. Science 265(5172): 679-82.

-Kass, MA, M Gordon, RE Morley, Jr., DW Meltzer, and JJ Goldberg (1987) Compliance with topical timolol treatment. Am J Ophthalmol 103(2): 188-93.

-Kates, RE, SR Harapat, DL Keefe, D Goldwater, and DC Harrison (1980) Influence of prolonged recumbency on drug disposition. Clin Pharmacol Ther 28(5): 624-8.

-Kato, M, BG Phillips, G Sigurdsson, K Narkiewicz, CA Pesek, and VK Somers (2000) Effects of sleep deprivation on neural circulatory control. Hypertension 35(5): 1173-5.

-Katzung, BG, Ed. (2007). Basic and Clinical Pharmacology. New York, McGraw Hill Medical.

-Keller, GA, ML Ponte, and G Di Girolamo Other drugs acting on nervous system associated with QT- interval prolongation. Curr Drug Saf 5(1): 105-11.

-Kelly, TH, RD Hienz, TJ Zarcone, RM Wurster, and JV Brady (2005) Crewmember performance before, during, and after spaceflight. J Exp Anal Behav 84(2): 227-41.

-Kennedy, AR, J Guan, and JH Ware (2007) Countermeasures against space radiation induced oxidative stress in mice. Radiat Environ Biophys 46(2): 201-3.

-Kennedy, RS, A Graybiel, RC McDonough, and FD Beckwith (1968) Symptomatology under storm conditions in the North Atlantic in control subjects and in persons with bilateral labyrinthine defects. Acta Otolaryngol 66(6): 533-40.

-Kennedy, RS, RC Odenheimer, DR Baltzley, WP Dunlap, and CD Wood (1990) Differential effects of scopolamine and amphetamine on microcomputer-based performance tests. Aviat Space Environ Med 61(7): 615-21.

-Killgore, WD, NL Grugle, DB Killgore, BP Leavitt, GI Watlington, S McNair, and TJ Balkin (2008) Restoration of risk-propensity during sleep deprivation: caffeine, dextroamphetamine, and modafinil. Aviat Space Environ Med 79(9): 867-74.

-Kitamura, Y, A Miyoshi, Y Murata, B Kalubi, H Fukui, and N Takeda (2004) Effect of glucocorticoid on upregulation of histamine H1 receptor mRNA in nasal mucosa of rats sensitized by exposure to toluene diisocyanate. Acta Otolaryngol 124(9): 1053-8.

-Klosterhalfen, S, S Kellermann, U Stockhorst, J Wolf, C Kirschbaum, G Hall, and P Enck (2005) Latent inhibition of rotation chair-induced nausea in healthy male and female volunteers. Psychosom Med 67(2): 335-40.

-Knipling, R, and J Wang (1995). Revised estimates of the US drowsy driver crash problem size based on general estimates system case reviews. Thirty-ninth Annual Proceedings of the Association for the Advancement of Automotive Medicine, Des Plaines, IL.

-Knudsen, TB, and GP Daston (2005) MIAME guidelines. Reprod Toxicol 19(3): 263.

-Ko, T, and J Evenden (2009) The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats. Psychopharmacology (Berl) 202(1-3): 67-78.

-Kohl, RL (1987) Failure of metoclopramide to control emesis or nausea due to stressful angular or linear acceleration. Aviat Space Environ Med 58(2): 125-31.

-Kohl, RL, DS Calkins, and AJ Mandell (1986) Arousal and stability: the effects of five new sympathomimetic drugs suggest a new principle for the prevention of space motion sickness. Aviat Space Environ Med 57(2): 137-43.

-Kohl, RL, DS Calkins, and RE Robinson (1991) Control of nausea and autonomic dysfunction with terfenadine, a peripherally acting antihistamine. Aviat Space Environ Med 62(5): 392-6.

-Kohl, RL, and S MacDonald (1991) New pharmacologic approaches to the prevention of space/motion sickness. J Clin Pharmacol 31(10): 934-46.

-Kojima, M, and K Kangawa (2005) Ghrelin: structure and function. Physiol Rev 85(2): 495-522.

-Kopacek, KB. (2007). "Absorption." The Merck Manual Retrieved 12/1/2009, from http://www.merck.com/mmpe/sec20/ch303/ch303c.html.

Kopacek, KB. (2007). "Bioavailablility." The Merck Manual Retrieved 12/1/2009, from http://www.merck.com/mmpe/sec20/ch303/ch303c.html.

-Kovachevich, I, S Kondratenko, AK Starodubtsev, and LG Repenkova (2009) Pharmacokinetics of acetaminophen adminstered in tablets and capsules under long-term space flight conditions. Pharmaceutical Chemical Journal 43(3): 130-133.

-Krasnoff, J, and P Painter (1999) The physiological consequences of bed rest and inactivity. Adv Ren Replace Ther 6(2): 124-32.

-Kruse, W, W Eggert-Kruse, J Rampmaier, B Runnebaum, and E Weber (1991) Dosage frequency and drug-compliance behaviour--a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 41(6): 589-92.

-Kruse, W, W Eggert-Kruse, J Rampmaier, B Runnebaum, and E Weber (1993) Compliance and adverse drug reactions: a prospective study with ethinylestradiol using continuous compliance monitoring. Clin Investig 71(6): 483-7.

-Kruse, W, P Koch-Gwinner, T Nikolaus, P Oster, G Schlierf, and E Weber (1992) Measurement of drug compliance by continuous electronic monitoring: a pilot study in elderly patients discharged from hospital. J Am Geriatr Soc 40(11): 1151-5.

-Kruse, W, and E Weber (1990) Dynamics of drug regimen compliance--its assessment by microprocessor- based monitoring. Eur J Clin Pharmacol 38(6): 561-5.

-Kuhn, E, V Brodan, M Brodanova, and K Rysanek (1969) Metabolic reflection of sleep deprivation. Act Nerv Super (Praha) 11(3): 165-74.

-Lackner, JR, and A Graybiel (1986) Head movements in non-terrestrial force environments elicit motion sickness: implications for the etiology of space motion sickness. Aviat Space Environ Med 57(5): 443-8.

-Lakin, WD, SA Stevens, and PL Penar (2007) Modeling intracranial pressures in microgravity: the influence of the blood-brain barrier. Aviat Space Environ Med 78(10): 932-6.

-Landauer, MR, V Srinivasan, and TM Seed (2003) Genistein treatment protects mice from ionizing radiation injury. J Appl Toxicol 23(6): 379-85.

-Laposky, AD, J Bass, A Kohsaka, and FW Turek (2008) Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett 582(1): 142-51.

-Laposky, AD, MA Bradley, DL Williams, J Bass, and FW Turek (2008) Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol 295(6): R2059-66.

-Lathers, CM, JM Riddle, SL Mulvagh, C Mukai, PH Diamandis, LG Dussack, MW Bungo, and JB Charles (1993) Echocardiograms during six hours of bedrest at head-down and head-up tilt and during space flight. J Clin Pharmacol 33(6): 535-43.

-Leach, CS (1979) A review of the consequences of fluid and electrolyte shifts in weightlessness. Acta Astronautica 6: 1123-1135.

-Leach, CS (1981) An overview of the endocrine and metabolic changes in manned space flight. Acta Astronautica 8: 977-986.

-Leach, CS (1991) Metabolism and biochemistry in hypogravity. Acta Astronaut 23: 105-8.

-Leach, CS, WC Alexander, and PC Johnson (1972) Adrenal and pituitary response of the Apollo 15 crew members. J Clin Endocrinol Metab 35(5): 642-5.

-Leach, CS, CP Alfrey, WN Suki, JI Leonard, PC Rambaut, LD Inners, SM Smith, HW Lane, and JM Krauhs (1996) Regulation of body fluid compartments during short-term spaceflight. J Appl Physiol 81(1): 105-16.

-Leach, CS, SI Altchuler, and NM Cintron-Trevino (1983) The endocrine and metabolic responses to space flight. Med Sci Sports Exerc 15(5): 432-40.

-Leach, CS, NM Cintron, and JM Krauhs (1991) Metabolic changes observed in astronauts. J Clin Pharmacol 31(10): 921-7.

-Leach, CS, LD Inners, and JB Charles (1991) Changes in total body water during spaceflight. J Clin Pharmacol 31(10): 1001-6.

-Leach, CS, PC Johnson, and NM Cintron (1988) The endocrine system in space flight. Acta Astronaut 17(2): 161-6.

-LeBlanc, A, V Schneider, L Shackelford, S West, V Oganov, A Bakulin, and L Voronin (2000) Bone mineral and lean tissue loss after long duration space flight. J Musculoskelet Neuronal Interact 1(2): 157- 60.

-LeBlanc, AD, TB Driscol, LC Shackelford, HJ Evans, NJ Rianon, SM Smith, DL Feeback, and D Lai (2002) Alendronate as an effective countermeasure to disuse induced bone loss. J Musculoskelet Neuronal Interact 2(4): 335-43.

-LeBlanc, AD, ER Spector, HJ Evans, and JD Sibonga (2007) Skeletal responses to space flight and the bed rest analog: a review. J Musculoskelet Neuronal Interact 7(1): 33-47.

-Lee, KC, JD Ma, and GM Kuo (2003) Pharmacogenomics: bridging the gap between science and practice. J Am Pharm Assoc (2003) 50(1): e1-14; quiz e15-7.

-Lehnert, BE, and R Iyer (2002) Exposure to low-level chemicals and ionizing radiation: reactive oxygen species and cellular pathways. Hum Exp Toxicol 21(2): 65-9.

-Leucuta, SE, and L Vlase (2006) Pharmacokinetics and metabolic drug interactions. Curr Clin Pharmacol 1(1): 5-20.

-Levine, BD, JH Zuckerman, and JA Pawelczyk (1997) Cardiac atrophy after bed-rest deconditioning: a nonneural mechanism for orthostatic intolerance. Circulation 96(2): 517-25.

-Levine, ME, JC Chillas, RM Stern, and GW Knox. (2000, Nov). "The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness." Aviat Space Environ Med 2000/11/22. Retrieved 11, 71, from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11086664.

-Lewy, AJ, VK Bauer, BP Hasler, AR Kendall, ML Pires, and RL Sack (2001) Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin. Brain Res 918(1-2): 96-100.

-Li, JJ, JC Sutton, A Nirschl, Y Zou, H Wang, C Sun, Z Pi, R Johnson, SR Krystek, Jr., R Seethala, R Golla, PG Sleph, BC Beehler, GJ Grover, A Fura, VP Vyas, CY Li, JZ Gougoutas, MA Galella, R Zahler, J Ostrowski, and LG Hamann (2007) Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications. J Med Chem 50(13): 3015-25.

-Liberman, UA, SR Weiss, J Broll, HW Minne, H Quan, NH Bell, J Rodriguez-Portales, RW Downs, Jr., J Dequeker, and M Favus (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333(22): 1437-43.

-Lilly, E (2004). Forteo. http://pi.lilly.com/us/forteo-medguide.pdf. p insert.

-Lim, J, and DF Dinges (2008) Sleep deprivation and vigilant attention. Ann N Y Acad Sci 1129: 305-22.

-Lim, J, JC Tan, S Parimal, DF Dinges, and MW Chee (2010) Sleep deprivation impairs object-selective attention: a view from the ventral visual cortex. PLoS One 5(2): e9087.

-Lindsay, KJ, PJ Coates, SA Lorimore, and EG Wright (2007) The genetic basis of tissue responses to ionizing radiation. Br J Radiol 80 Spec No 1: S2-6.

-Lovejoy, JC, SR Smith, JJ Zachwieja, GA Bray, MM Windhauser, PJ Wickersham, JD Veldhuis, R Tulley, and JA de la Bretonne (1999) Low-dose T(3) improves the bed rest model of simulated weightlessness in men and women. Am J Physiol 277(2 Pt 1): E370-9.

-Lu, SK, S Bai, K Javeri, and LJ Brunner (2002) Altered cytochrome P450 and P-glycoprotein levels in rats during simulated weightlessness. Aviat Space Environ Med 73(2): 112-8.

-Lucot, JB, RS Obach, S McLean, and JW Watson (1997) The effect of CP-99994 on the responses to provocative motion in the cat. Br J Pharmacol 120(1): 116-20.

-Macho, L, M Fickova, S Zorad, L Serova, and I Popova (1991) Plasma insulin levels and insulin receptors in liver and adipose tissue of rats after space flight. Physiologist 34(1 Suppl): S90-1.

-Macho, L, J Koska, L Ksinantova, K Pacak, T Hoff, VB Noskov, AI Grigoriev, M Vigas, and R Kvetnansky (2003) The response of endocrine system to stress loads during space flight in human subject. Adv Space Res 31(6): 1605-10.

-Macho, L, R Kvetnansky, M Fickova, IA Popova, and A Grigoriev (2001) Effects of exposure to space flight on endocrine regulations in experimental animals. Endocr Regul 35(2): 101-14.

-Macho, L, R Kvetnansky, S Nemeth, M Fickova, I Popova, L Serova, and AI Grigoriev (1996) Effects of space flight on endocrine system function in experimental animals. Environ Med 40(2): 95-111.

-Macho, L, R Kvetnansky, M Vigas, S Nemeth, I Popova, RA Tigranian, VB Noskov, L Serova, and IA Grigoriev (1991) Effect of space flights on plasma hormone levels in man and in experimental animal. Acta Astronaut 23: 117-21.

-Macho, L, S Nemeth, R Kvetnansky, M Fickova, RA Tigranian, and L Serova (1982) Metabolic changes in the animals subjected to space flight. Acta Astronaut 9(6-7): 385-9.

-Mackiewicz, M, KR Shockley, MA Romer, RJ Galante, JE Zimmerman, N Naidoo, DA Baldwin, ST Jensen, GA Churchill, and AI Pack (2007) Macromolecule biosynthesis: a key function of sleep. Physiol Genomics 31(3): 441-57.

-Madeddu, C, and G Mantovani (2009) An update on promising agents for the treatment of cancer cachexia. Curr Opin Support Palliat Care 3(4): 258-62.

-Maggi, L, L Segale, E Ochoa Machiste, A Buttafava, A Faucitano, and U Conte (2003) Chemical and physical stability of hydroxypropylmethylcellulose matrices containing diltiazem hydrochloride after gamma irradiation. J Pharm Sci 92(1): 131-41.

-Maggi, L, L Segale, E Ochoa Machiste, A Faucitano, A Buttafava, and U Conte (2004) Polymers-gamma ray interaction. Effects of gamma irradiation on modified release drug delivery systems for oral administration. Int J Pharm 269(2): 343-51.

-Maillet, A, G Gauquelin, HC Gunga, JO Fortrat, K Kirsch, A Guell, A Bizollon Ch, and C Gharib (1995) Blood volume regulating hormones response during two space related simulation protocols: four-week confinement and head-down bed-rest. Acta Astronaut 35(8): 547-52.

-Makris, AP, CR Rush, RC Frederich, AC Taylor, and TH Kelly (2007) Behavioral and subjective effects of d- amphetamine and modafinil in healthy adults. Exp Clin Psychopharmacol 15(2): 123-33.

-Manda, K, and AL Bhatia (2003) Pre-administration of beta-carotene protects tissue glutathione and lipid peroxidation status following exposure to gamma radiation. J Environ Biol 24(4): 369-72.

-Manda, K, M Ueno, and K Anzai (2008) Melatonin mitigates oxidative damage and apoptosis in mouse cerebellum induced by high-LET 56Fe particle irradiation. J Pineal Res 44(2): 189-96.

-Manda, K, M Ueno, and K Anzai (2008) Memory impairment, oxidative damage and apoptosis induced by space radiation: ameliorative potential of alpha-lipoic acid. Behav Brain Res 187(2): 387-95.

-Manda, K, M Ueno, and K Anzai (2008) Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: ameliorative potential of the melatonin metabolite, AFMK. J Pineal Res 45(4): 430-8.

-Manda, K, M Ueno, and K Anzai (2009) Cranial irradiation-induced inhibition of neurogenesis in hippocampal dentate gyrus of adult mice: attenuation by melatonin pretreatment. J Pineal Res 46(1): 71-8.

-Manda, K, M Ueno, T Moritake, and K Anzai (2007) alpha-Lipoic acid attenuates x-irradiation-induced oxidative stress in mice. Cell Biol Toxicol 23(2): 129-37.

-Mano, T (2005) Autonomic neural functions in space. Curr Pharm Biotechnol 6(4): 319-24.

-Mano, T, and S Iwase (2003) Sympathetic nerve activity in hypotension and orthostatic intolerance. Acta Physiol Scand 177(3): 359-65.

-Martin, DS, and JV Meck (2004) Presyncopal/non-presyncopal outcomes of post spaceflight stand tests are consistent from flight to flight. Aviat Space Environ Med 75(1): 65-7.

-Matsnev, EI, and D Bodo (1984) Experimental assessment of selected antimotion drugs. Aviat Space Environ Med 55(4): 281-6.

-Mattie, H, WA Craig, and JC Pechere (1989) Determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother 24(3): 281-93.

-McClung, MR, EM Lewiecki, SB Cohen, MA Bolognese, GC Woodson, AH Moffett, M Peacock, PD Miller, SN Lederman, CH Chesnut, D Lain, AJ Kivitz, DL Holloway, C Zhang, MC Peterson, and PJ Bekker (2006) Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 354(8): 821-31.

-McLachlan, AJ, and I Ramzan (2006) Meals and medicines. Austrailian Prescriber 29(2): 40-42.

-Meck, JV, S Dreyer, and L Warren (2009) Long-duration head-down bed rest: Project overview, vital signs, and fluid balance. Aviation Space and Environmental Medicine 80(5, Supplement): A1-A8.

-Meck, JV, WW Waters, MG Ziegler, HF deBlock, PJ Mills, D Robertson, and PL Huang (2004) Mechanisms of postspaceflight orthostatic hypotension: low alpha1-adrenergic receptor responses before flight and central autonomic dysregulation postflight. Am J Physiol Heart Circ Physiol 286(4): H1486-95.

-Meehan, JP (1971) Biosatellite 3: a physiological interpretation. Life Sci Space Res 9: 83-98.

-Megighian, D, and A Martini (1980) Motion sickness and space sickness: clinical and experimental findings. ORL J Otorhinolaryngol Relat Spec 42(4): 185-95.

-Mehta, SK, RJ Cohrs, B Forghani, G Zerbe, DH Gilden, and DL Pierson (2004) Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J Med Virol 72(1): 174-9.

-Meier-Ewert, HK, PM Ridker, N Rifai, MM Regan, NJ Price, DF Dinges, and JM Mullington (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43(4): 678-83.

-Merrill, AH, Jr., M Hoel, E Wang, RE Mullins, JL Hargrove, DP Jones, and IA Popova (1990) Altered carbohydrate, lipid, and xenobiotic metabolism by liver from rats flown on Cosmos 1887. FASEB J 4(1): 95-100.

-Merrill, AH, Jr., E Wang, DP Jones, and JL Hargrove (1987) Hepatic function in rats after spaceflight: effects on lipids, glycogen, and enzymes. Am J Physiol 252(2 Pt 2): R222-6.

-Merrill, AH, Jr., E Wang, R LaRocque, RE Mullins, ET Morgan, JL Hargrove, HL Bonkovsky, and IA Popova (1992) Differences in glycogen, lipids, and enzymes in livers from rats flown on COSMOS 2044. J Appl Physiol 73(2 Suppl): 142S-147S.

-Mieda, M, and T Sakurai (2009) Integrative physiology of orexins and orexin receptors. CNS Neurol Disord Drug Targets 8(4): 281-95.

-Migeotte, PF, GK Prisk, and M Paiva (2003) Microgravity alters respiratory sinus arrhythmia and short- term heart rate variability in humans. Am J Physiol Heart Circ Physiol 284(6): H1995-2006.

-Miner, JN, W Chang, MS Chapman, PD Finn, MH Hong, FJ Lopez, KB Marschke, J Rosen, W Schrader, R Turner, A van Oeveren, H Viveros, L Zhi, and A Negro-Vilar (2007) An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology 148(1): 363-73.

-Misaki, T, N Kyoda, S Oka, K Takada, T Kunimatu, and A Tajima (1997) Timing and side effects of flumazenil for dental outpatients receiving intravenous sedation with midazolam. Anesth Prog 44(4): 127-31.

-Miyamoto, M (2009) Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS Neurosci Ther 15(1): 32-51.

-Mollicone, DJ, HP Van Dongen, NL Rogers, and DF Dinges (2008) Response Surface Mapping of Neurobehavioral Performance: Testing the Feasibility of Split Sleep Schedules for Space Operations. Acta Astronaut 63(7-10): 833-840.

-Monk, TH, DJ Buysse, BD Billy, KS Kennedy, and LM Willrich (1998) Sleep and circadian rhythms in four orbiting astronauts. J Biol Rhythms 13(3): 188-201.

-Monk, TH, KS Kennedy, LR Rose, and JM Linenger (2001) Decreased human circadian pacemaker influence after 100 days in space: a case study. Psychosom Med 63(6): 881-5.

-Montgomery, LD (1993) Body volume changes during simulated microgravity I: Technique and comparison of men and women during horizontal bed rest. Aviat Space Environ Med 64(10): 893-8.

-Montgomery, LD, AJ Parmet, and CR Booher (1993) Body volume changes during simulated microgravity: auditory changes, segmental fluid redistribution, and regional hemodynamics. Ann Biomed Eng 21(4): 417-33.

-Morley, JE, FE Kaiser, HM Perry, 3rd, P Patrick, PM Morley, PM Stauber, B Vellas, RN Baumgartner, and PJ Garry (1997) Longitudinal changes in testosterone, luteinizing hormone, and follicle- stimulating hormone in healthy older men. Metabolism 46(4): 410-3.

-Morrow, GR (1984) Susceptibility to motion sickness and chemotherapy-induced side-effects. Lancet 1(8373): 390-1.

-Muller, PJ, and J Vernikos-Danellis (1968) Alteration in drug toxicity by environmental variables. Proc West Pharmacol Soc 11: 52-3.

-Mullington, JM, M Haack, M Toth, JM Serrador, and HK Meier-Ewert (2009) Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis 51(4): 294- 302.

-Mulvagh, SL, JB Charles, JM Riddle, TL Rehbein, and MW Bungo (1991) Echocardiographic evaluation of the cardiovascular effects of short-duration spaceflight. J Clin Pharmacol 31(10): 1024-6.

-Murley, JS, Y Kataoka, CJ Weydert, LW Oberley, and DJ Grdina (2006) Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065. Free Radic Biol Med 40(6): 1004-16.

-Muth, ER (2006) Motion and space sickness: intestinal and autonomic correlates. Auton Neurosci 129(1- 2): 58-66.

-Nachum, Z, A Shupak, and CR Gordon (2006) Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 45(6): 543- 66.

-Narayanan, R, ML Mohler, CE Bohl, DD Miller, and JT Dalton (2008) Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal 6: e010.

-Neer, RM, CD Arnaud, JR Zanchetta, R Prince, GA Gaich, JY Reginster, AB Hodsman, EF Eriksen, S Ish- Shalom, HK Genant, O Wang, and BH Mitlak (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19): 1434-41.

-Nicholson, AN (1972) Sleep patterns in the aerospace environment. Proc R Soc Med 65(2): 192-4.

-Nickerson, CA, CM Ott, SJ Mister, BJ Morrow, L Burns-Keliher, and DL Pierson (2000) Microgravity as a novel environmental signal affecting Salmonella enterica serovar Typhimurium virulence. Infect Immun 68(6): 3147-52.

-Nickerson, CA, CM Ott, JW Wilson, R Ramamurthy, CL LeBlanc, K Honer zu Bentrup, T Hammond, and DL Pierson (2003) Low-shear modeled microgravity: a global environmental regulatory signal affecting bacterial gene expression, physiology, and pathogenesis. J Microbiol Methods 54(1): 1- 11.

-Nickerson, CA, CM Ott, JW Wilson, R Ramamurthy, and DL Pierson (2004) Microbial responses to microgravity and other low-shear environments. Microbiol Mol Biol Rev 68(2): 345-61.

-NIH. (2010). "NIH renews major research program to develop medical countermeasures against radiological and nuclear threats", from http://www.nih.gov/news/health/aug2010/niaid-19.htm.

-Nimmo, WS, and LF Prescott (1978) The influence of posture on paracetemol absorption. Br J Clin Pharmacol 5: 348-349.

-Norfleet, WT, JJ Degioanni, DS Calkins, MF Reschke, MW Bungo, FA Kutyna, and JL Homick (1992) Treatment of motion sickness in parabolic flight with buccal scopolamine. Aviat Space Environ Med 63(1): 46-51.

-Norsk, P, NJ Christensen, P Bie, A Gabrielsen, M Heer, and C Drummer (2000) Unexpected renal responses in space. Lancet 356(9241): 1577-8.

-Norsk, P, C Drummer, L Rðcker, F Strollo, NJ Christensen, J Warberg, P Bie, C Stadeager, LB Johansen, M Heer, H-C Gunga, and R Gerzer (1995) Renal and endocrine responses in humans to isotonic saline infusion during microgravity. Journal of Applied Physiology 78: 2253-2259.

-Noverr, MC, and GB Huffnagle (2004) Does the microbiota regulate immune responses outside the gut? Trends Microbiol 12(12): 562-8.

-Nunez, A, ML Rodrigo-Angulo, ID Andres, and M Garzon (2009) Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis. Curr Neuropharmacol 7(1): 50-9.

-Odvina, CV, S Levy, S Rao, JE Zerwekh, and DS Rao Unusual mid-shaft fractures during long-term bisphosphonate therapy. Clin Endocrinol (Oxf) 72(2): 161-8.

-Ogawa, Y, T Kanbayashi, Y Saito, Y Takahashi, T Kitajima, K Takahashi, Y Hishikawa, and T Shimizu (2003) Total sleep deprivation elevates blood pressure through arterial baroreflex resetting: a study with microneurographic technique. Sleep 26(8): 986-9.

-Ogneva, IV, VA Kurushin, EG Altaeva, EV Ponomareva, and BS Shenkman (2010) Effect of short-term gravitational unloading on rat and mongolian gerbil muscles. J Muscle Res Cell Motil.

-Oman, CM (1990) Motion sickness: a synthesis and evaluation of the sensory conflict theory. Can J Physiol Pharmacol 68(2): 294-303.

-Oman, CM (1998) Sensory conflict theory and space sickness: our changing perspective. J Vestib Res 8(1): 51-6.

-Oosterhuis, B, and JH Jonkman (1993) Pharmacokinetic studies in healthy volunteers in the context of in vitro/in vivo correlations. Eur J Drug Metab Pharmacokinet 18(1): 19-30.

-Ortega, J, H. J., and DL Harm (2008). Space and Entry Motion Sickness. Principles of Clinical Medicine for Space FLight. MR Barrat and SL Pool. New York, Spinger.

-Oswald, I (1976) The function of sleep. Postgrad Med J 52(603): 15-8.

-Otmani, S, A Demazieres, C Staner, N Jacob, T Nir, N Zisapel, and L Staner (2008) Effects of prolonged- release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol 23(8): 693-705.

-Page, ST, BT Marck, JM Tolliver, and AM Matsumoto (2008) Tissue selectivity of the anabolic steroid, 19- nor-4-androstenediol-3beta,17beta-diol in male Sprague Dawley rats: selective stimulation of muscle mass and bone mineral density relative to prostate mass. Endocrinology 149(4): 1987- 93.

-Pageau, SC (2009) Denosumab. MAbs 1(3): 210-5.

-Pang, W, C Li, Y Zhao, S Wang, W Dong, P Jiang, and J Zhang (2008) The environmental light influences the circulatory levels of retinoic acid and associates with hepatic lipid metabolism. Endocrinology 149(12): 6336-42.

-Parker, DE (1977) Labyrinth and cerebral-spinal fluid pressure changes in guinea pigs and monkeys during simulated zero G. Aviat Space Environ Med 48(4): 356-61.

-Parnes, LS, SK Agrawal, and J Atlas (2003) Diagnosis and management of benign paroxysmal positional vertigo (BPPV). CMAJ 169(7): 681-93.

-Parrott, AC, and K Wesnes (1987) Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects. Psychopharmacology (Berl) 92(4): 513-9.

-Patat, A, I Paty, and I Hindmarch (2001) Pharmacodynamic profile of Zaleplon, a new non- benzodiazepine hypnotic agent. Hum Psychopharmacol 16(5): 369-392.

-Paule, MG, JJ Chelonis, DJ Blake, and JL Dornhoffer (2004) Effects of drug countermeasures for space motion sickness on working memory in humans. Neurotoxicol Teratol 26(6): 825-37.

-Pavy-Le Traon, A, A Guell, S Saivin, G Houin, C Soulez-Lariviere, and M Pujos (1994) The use of medicaments in space--therapeutic measures and potential impact of pharmacokinetics due to weightlessness. ESA J 18(1): 33-50.

-Pavy-Le Traon, A, M Heer, MV Narici, J Rittweger, and J Vernikos (2007) From space to Earth: advances in human physiology from 20 years of bed rest studies (1986-2006). Eur J Appl Physiol 101(2): 143-94.

-Payne, DA, SK Mehta, SK Tyring, RP Stowe, and DL Pierson (1999) Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. Aviat Space Environ Med 70(12): 1211-3.<ref name="Payne et al., 1999".Payne, DA, SK Mehta, SK Tyring, RP Stowe, and DL Pierson (1999) Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. Aviat Space Environ Med 70(12): 1211-3.

-Pecaut, MJ, and DS Gridley The impact of mouse strain on iron ion radio-immune response of leukocyte populations. Int J Radiat Biol 86(5): 409-19.

-Perhonen, MA, F Franco, LD Lane, JC Buckey, CG Blomqvist, JE Zerwekh, RM Peshock, PT Weatherall, and BD Levine (2001) Cardiac atrophy after bed rest and spaceflight. J Appl Physiol 91(2): 645-53.

-Petrie, K, AG Dawson, L Thompson, and R Brook (1993) A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol Psychiatry 33(7): 526-30.

-Pierson, DL, RP Stowe, TM Phillips, DJ Lugg, and SK Mehta (2005) Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun 19(3): 235-42.

-Pietrzyk, RA, JA Jones, CF Sams, and PA Whitson (2007) Renal stone formation among astronauts. Aviat Space Environ Med 78(4 Suppl): A9-13.

-Plant, JR, and DB MacLeod (1994) Response of a promethazine-induced coma to flumazenil. Ann Emerg Med 24(5): 979-82.

-Platts, S (2008). Risk of Cardiac Ryththm Problems During Spaceflight. H NASA, HHC.

-Platts, S (2008). Risk of Orthostatic Intolerance During Re-exposure to Gravity. H NASA, HHC.

-Platts, SH, DS Martin, MB Stenger, SA Perez, LC Ribeiro, R Summers, and JV Meck (2009) Cardiovascular adaptations to long-duration head-down bed rest. Aviat Space Environ Med 80(5 Suppl): A29-36.

-Platts, SH, SJ Shi, and JV Meck (2006) Akathisia with combined use of midodrine and promethazine. JAMA 295(17): 2000-1.

-Platts, SH, JA Tuxhorn, LC Ribeiro, MB Stenger, SM Lee, and JV Meck (2009) Compression garments as countermeasures to orthostatic intolerance. Aviat Space Environ Med 80(5): 437-42.

-Platts, SH, MG Ziegler, WW Waters, and JV Meck (2006) Hemodynamic effects of midodrine after spaceflight in astronauts without orthostatic hypotension. Aviat Space Environ Med 77(4): 429- 33.

-Pompeiano, O, P d'Ascanio, C Centini, M Pompeiano, and E Balaban (2002) Gene expression in rat vestibular and reticular structures during and after space flight. Neuroscience 114(1): 135-55.

-Putcha, L (1999) Pharmacotherapeutics in space. J Gravit Physiol 6(1): P165-8.

-Putcha, L (2009) Data mining - Pharmacotherapeutics of Space Motion Sickness. Putcha, L (2009) Data mining - Pharmacotherapeutics of Space Motion Sickness.

-Putcha, L, KL Berens, TH Marshburn, HJ Ortega, and RD Billica (1999) Pharmaceutical use by U.S. astronauts on space shuttle missions. Aviat Space Environ Med 70(7): 705-8.

-Putcha, L, KJ Tietze, DW Bourne, CM Parise, RP Hunter, and NM Cintron (1996) Bioavailability of intranasal scopolamine in normal subjects. J Pharm Sci 85(8): 899-902.

-Queckenberg, C, and U Fuhr (2009) Influence of posture on pharmacokinetics. Eur J Clin Pharmacol 65(2): 109-19.

-Queckenberg, C, J Meins, B Wachall, O Doroshyenko, D Tomalik-Scharte, B Bastian, M Abdel-Tawab, and U Fuhr (2009) Absorption, pharmacokinetics and safety of triclosan after dermal administration. Antimicrob Agents Chemother.

-Racine, RN, and SM Cormier (1992) Effect of spaceflight on rat hepatocytes: a morphometric study. J Appl Physiol 73(2 Suppl): 136S-141S.

-Rambaut, PC, CS Leach, and JI Leonard (1977) Observations in energy balance in man during spaceflight. Am J Physiol 233(5): R208-12.

-Rambaut, PC, CS Leach, and GD Whedon (1977) Metabolic energy requirements during manned orbital Skylab missions. Life Sci Space Res 15: 187-91.

-Ramsdell, CD, TJ Mullen, GH Sundby, S Rostoft, N Sheynberg, N Aljuri, M Maa, R Mukkamala, D Sherman, K Toska, J Yelle, D Bloomfield, GH Williams, and RJ Cohen (2001) Midodrine prevents orthostatic intolerance associated with simulated spaceflight. J Appl Physiol 90(6): 2245-8.

-Ray, CA (2008) New insights into orthostatic hypotension. Am J Physiol Regul Integr Comp Physiol 294(5): R1575-6.

-Reason, JT, and JJ Brand (1975). Motion Sickness. London, Academic Press.

-Rechtscheffen, A, and A Kales, Eds. (1968). A manual for standardaized terminology and scoring system for sleep stages of human sujects. Washington DC, Public Health Service, US Government Printing Office.

-Reid, K, JL Palmer, RJ Wright, SA Clemes, C Troakes, HS Somal, F House, and JR Stott (2000) Comparison of the neurokinin-1 antagonist GR205171, alone and in combination with the 5-HT3 antagonist ondansetron, hyoscine and placebo in the prevention of motion-induced nausea in man. Br J Clin Pharmacol 50(1): 61-4.

-Reiter, RJ, DX Tan, and MD Maldonado (2005) Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res 39(2): 215-6.

-Renwick, AG, CH Ahsan, VF Challenor, R Daniels, BS Macklin, DG Waller, and CF George (1992) The influence of posture on the pharmacokinetics of orally administered nifedipine. Br J Clin Pharmacol 34(4): 332-6.

-Reschke, MF, JJ Bloomberg, DL Harm, WH Paloski, C Layne, and V McDonald (1998) Posture, locomotion, spatial orientation, and motion sickness as a function of space flight. Brain Res Brain Res Rev 28(1-2): 102-17.

-Ricci, G, A Catizone, R Esposito, and M Galdieri (2004) Microgravity effect on testicular functions. J Gravit Physiol 11(2): P61-2.

-Ricci, G, R Esposito, A Catizone, and M Galdieri (2008) Direct effects of microgravity on testicular function: analysis of hystological, molecular and physiologic parameters. J Endocrinol Invest 31(3): 229-37.

-Rice, L, W Ruiz, T Driscoll, CE Whitley, R Tapia, DL Hachey, GF Gonzales, and CP Alfrey (2001) Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass. Ann Intern Med 134(8): 652-6.

-Richardson, GS, PC Zee, S Wang-Weigand, L Rodriguez, and X Peng (2008) Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. J Clin Sleep Med 4(5): 456-61.

-Ridout, F, and I Hindmarch (2003) The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psychomotor function in healthy Japanese volunteers. Ann Allergy Asthma Immunol 90(4): 404-10.

-Rimmer, DW, DB Boivin, TL Shanahan, RE Kronauer, JF Duffy, and CA Czeisler (2000) Dynamic resetting of the human circadian pacemaker by intermittent bright light. Am J Physiol Regul Integr Comp Physiol 279(5): R1574-9.

-Rittweger, J, HM Frost, H Schiessl, H Ohshima, B Alkner, P Tesch, and D Felsenberg (2005) Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study. Bone 36(6): 1019-29.

-Roberts, MS, and MJ Denton (1980) Effect of posture and sleep on pharmacokinetics. I. Amoxycillin. Eur J Clin Pharmacol 18(2): 175-83.

-Ross, MD, and DL Tomko (1998) Effect of gravity on vestibular neural development. Brain Res Brain Res Rev 28(1-2): 44-51.

-Rossum, AC, ML Wood, SL Bishop, H Deblock, and JB Charles (1997) Evaluation of cardiac rhythm disturbances during extravehicular activity. Am J Cardiol 79(8): 1153-5.

-Rossum, AC, MG Ziegler, and JV Meck (2001) Effect of spaceflight on cardiovascular responses to upright posture in a 77-year-old astronaut. Am J Cardiol 88(11): 1335-7.

-Rowland, M (1975) Hemodynamic factors in pharmacokinetics. Triangle 14(3-4): 109-16.

-Roy, TA, MR Blackman, SM Harman, JD Tobin, M Schrager, and EJ Metter (2002) Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab 283(2): E284-94.

-Rumble, RH, MS Roberts, and MJ Denton (1991) Effects of posture and sleep on the pharmacokinetics of paracetamol (acetaminophen) and its metabolites. Clin Pharmacokinet 20(2): 167-73.

-Sack, RL, D Auckley, RR Auger, MA Carskadon, KP Wright, Jr., MV Vitiello, and IV Zhdanova (2007) Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review. Sleep 30(11): 1460-83.

-Sack, RL, RJ Hughes, DM Edgar, and AJ Lewy (1997) Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? Sleep 20(10): 908-15.

-Saini, SD, P Schoenfeld, K Kaulback, and MC Dubinsky (2009) Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 15(6): e22-33.

-Saivin, S, A Pavy-Le Traon, A Cornac, A Guell, and G Houin (1995) Impact of a four-day head-down tilt (-6 degrees) on lidocaine pharmacokinetics used as probe to evaluate hepatic blood flow. J Clin Pharmacol 35(7): 697-704.

-Saivin, S, A Pavy-Le Traon, C Soulez-LaRiviere, A Guell, and G Houin (1997) Pharmacology in space: pharmacokinetics. Adv Space Biol Med 6: 107-21.

-Sanger, GJ, and PL Andrews (2006) Treatment of nausea and vomiting: gaps in our knowledge. Auton Neurosci 129(1-2): 3-16.

-Santucci, D, N Francia, V Trincia, F Chiarotti, L Aloe, and E Alleva (2009) A mouse model of neurobehavioural response to altered gravity conditions: an ontogenetical study. Behav Brain Res 197(1): 109-18.

-Santy, PA, and MW Bungo (1991) Pharmacologic considerations for Shuttle astronauts. J Clin Pharmacol 31(10): 931-3.

-Sato, G, A Uno, A Horii, H Umehara, Y Kitamura, K Sekine, K Tamura, H Fukui, and N Takeda (2009) Effects of hypergravity on histamine H1 receptor mRNA expression in hypothalamus and brainstem of rats: implications for development of motion sickness. Acta Otolaryngol 129(1): 45- 51.

-Sayet, I, G Neuilly, J Mironneau, and C Mironneau (1995) Influence of spaceflight, hindlimb suspension, and venous occlusion on alpha 1-adrenoceptors in rat vena cava. J Appl Physiol 78(5): 1882-8.

-Scharf, MB, T Roth, GW Vogel, and JK Walsh (1994) A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 55(5): 192-9.

-Schlyter, P. (2006). "Radiometry and photometry in astronmoy FAQ." Retrieved 11/12/2009, from http://stjarnhimlen.se/comp/radfaq.html#10.

-Schneeman, BO (2002) Gastrointestinal physiology and functions. Br J Nutr 88 Suppl 2: S159-63.

-Schneider, S, V Brummer, S Gobel, H Carnahan, A Dubrowski, and HK Struder (2007) Parabolic flight experience is related to increased release of stress hormones. Eur J Appl Physiol 100(3): 301-8.

-Schroeder, DJ, WE Collins, and GW Elam (1985) Effects of some motion sickness suppressants on static and dynamic tracking performance. Aviat Space Environ Med 56(4): 344-50.

-Schuck, EL, M Grant, and H Derendorf (2005) Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers. J Clin Pharmacol 45(7): 822-31.

-Schutte-Rodin, S, L Broch, D Buysse, C Dorsey, and M Sateia (2008) Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4(5): 487-504.

-Sedlacek, HS, DS Ramsey, JF Boucher, JS Eagleson, GA Conder, and RG Clemence (2008) Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs. J Vet Pharmacol Ther 31(6): 533-7.

-Sellmeyer, DE, M Schloetter, and A Sebastian (2002) Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet. J Clin Endocrinol Metab 87(5): 2008-12.

-Sener, G, L Kabasakal, BM Atasoy, C Erzik, A Velioglu-Ogunc, S Cetinel, N Gedik, and BC Yegen (2006) Ginkgo biloba extract protects against ionizing radiation-induced oxidative organ damage in rats. Pharmacol Res 53(3): 241-52.

-Senzaki, H, T Yasui, A Okada, Y Ito, K Tozawa, and K Kohri (2004) Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model. Urol Res 32(3): 223-8.

-Serrador, JM, TT Schlegel, FO Black, and SJ Wood (2005) Cerebral hypoperfusion precedes nausea during centrifugation. Aviat Space Environ Med 76(2): 91-6.

-Serrador, JM, TT Schlegel, FO Black, and SJ Wood (2009) Vestibular effects on cerebral blood flow. BMC Neurosci 10: 119.

-Serrador, JM, JK Shoemaker, TE Brown, MS Kassam, RL Bondar, and TT Schlegel (2000) Cerebral vasoconstriction precedes orthostatic intolerance after parabolic flight. Brain Res Bull 53(1): 113-20.

-Shah, KG, R Wu, A Jacob, SA Blau, Y Ji, W Dong, CP Marini, TS Ravikumar, GF Coppa, and P Wang (2009) Human ghrelin ameliorates organ injury and improves survival after radiation injury combined with severe sepsis. Mol Med 15(11-12): 407-14.

-Shargel, L, S Wu-Pong, and AB-C Wu (2005). Appplied Biopharmaceutics and Pharmacokinetics. New York, McGraw-Hill.

-Shi, S-J, SH Platts, MB Stenger, MG Ziegler, and JV Meck (2010) Effects of Midodrine, promethazine, and their combination on orthostatic intolerance in normal subjects. Aviation, Space, and Environmental Medicine in review.

-Shi, SJ, DA South, and JV Meck (2004) Fludrocortisone does not prevent orthostatic hypotension in astronauts after spaceflight. Aviat Space Environ Med 75(3): 235-9.

-Shilov, VM, NN Lizko, OK Borisova, and VY Prokhorov (1971) Changes in the microflora of man during long-term confinement. Life Sci Space Res 9: 43-9.

-Shiraishi, M, M Schou, M Gybel, NJ Christensen, and P Norsk (2002) Comparison of acute cardiovascular responses to water immersion and head-down tilt in humans. J Appl Physiol 92(1): 264-8.

-Sibonga, J (2008). Risk of Accelerated Osteoporosis. H NASA, HHC.

-Sibonga, J (2008). Risk of Bone Fracture. H NASA, HHC.

-Siegel, JM (2009) Sleep viewed as a state of adaptive inactivity. Nat Rev Neurosci 10(10): 747-53.

-Sih, R, JE Morley, FE Kaiser, HM Perry, 3rd, P Patrick, and C Ross (1997) Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82(6): 1661-7.

-Simpson, N, and DF Dinges (2007) Sleep and inflammation. Nutr Rev 65(12 Pt 2): S244-52.

-Siriwardena, AN, MZ Qureshi, JV Dyas, H Middleton, and R Orner (2008) Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. Br J Gen Pract 58(551): 417-22.

-Siriwardena, AN, Z Qureshi, S Gibson, S Collier, and M Latham (2006) GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract 56(533): 964-7.

-Slattery, JT, JM Wilson, TF Kalhorn, and SD Nelson (1987) Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans. Clin Pharmacol Ther 41(4): 413-8.

-Smith, RF, K Stanton, D Stoop, W Janusz, and PH King (1976) Quantitative electrocardiography during extended space flight: the second manned Skylab mission. Aviat Space Environ Med 47(4): 353- 9.

-Smith, SM, ME Wastney, BV Morukov, IM Larina, LE Nyquist, SA Abrams, EN Taran, CY Shih, JL Nillen, JE Davis-Street, BL Rice, and HW Lane (1999) Calcium metabolism before, during, and after a 3-mo spaceflight: kinetic and biochemical changes. Am J Physiol 277(1 Pt 2): R1-10.

-Smith, SM, and SR Zwart (2008) Nutritional biochemistry of spaceflight. Adv Clin Chem 46: 87-130.

-Smith, SM, SR Zwart, V Kloeris, and M Heer (2009). Nutrient-Drug Interactions. Nutritional Biochemistry of Space Flight. New York, Nova Science.

-Smith, SM, SR Zwart, V Kloeris, and M Heer (2009). Space programs and Space Food Systems. Nutritional Biochemistry of Space Flight. New York, Nova Science.

-Snyder, PJ, H Peachey, JA Berlin, P Hannoush, G Haddad, A Dlewati, J Santanna, L Loh, DA Lenrow, JH Holmes, SC Kapoor, LE Atkinson, and BL Strom (2000) Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85(8): 2670-7.

-Sockol, MD, DA Raichlen, and H Pontzer (2007) Chimpanzee locomotor energetics and the origin of human bipedalism. Proc Natl Acad Sci U S A 104(30): 12265-9.

-Song, QH, K Toriizuka, T Kobayashi, K Iijima, T Hong, and JC Cyong (2002) Effect of Kampo herbal medicines on murine water metabolism in a microgravity environment. Am J Chin Med 30(4): 617-27.

-Soyal, D, A Jindal, I Singh, and PK Goyal (2007) Modulation of radiation-induced biochemical alterations in mice by rosemary (Rosemarinus officinalis) extract. Phytomedicine 14(10): 701-5.

-Spector, ER, SM Smith, and JD Sibonga (2009) Skeletal effects of long-duration head-down bed rest. Aviat Space Environ Med 80(5 Suppl): A23-8.

-Spiller, HA, D Borys, JR Griffith, W Klein-Schwartz, A Aleguas, D Sollee, DA Anderson, and TS Sawyer (2009) Toxicity from modafinil ingestion. Clin Toxicol (Phila) 47(2): 153-6.

-Srinivasan, V, SR Pandi-Perumal, I Trahkt, DW Spence, B Poeggeler, R Hardeland, and DP Cardinali (2009) Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Int J Neurosci 119(6): 821-46.

-Srinivasan, V, DW Spence, SR Pandi-Perumal, I Trakht, and DP Cardinali (2008) Jet lag: therapeutic use of melatonin and possible application of melatonin analogs. Travel Med Infect Dis 6(1-2): 17-28.

-Stein, TP, and MJ Leskiw (2000) Oxidant damage during and after spaceflight. Am J Physiol Endocrinol Metab 278(3): E375-82.

-Stepaniak, PC, SR Ramchandani, and JA Jones (2007) Acute urinary retention among astronauts. Aviat Space Environ Med 78(4 Suppl): A5-8.

-Stern, RM, KL Koch, HW Leibowitz, IM Lindblad, CL Shupert, and WR Stewart (1985) Tachygastria and motion sickness. Aviat Space Environ Med 56(11): 1074-7.

-Stickney, DR, C Dowding, S Authier, A Garsd, N Onizuka-Handa, C Reading, and JM Frincke (2007) 5- androstenediol improves survival in clinically unsupported rhesus monkeys with radiation- induced myelosuppression. Int Immunopharmacol 7(4): 500-5.

-Stott, JR, GR Barnes, RJ Wright, and CJ Ruddock (1989) The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties. Br J Clin Pharmacol 27(2): 147-57.

-Sullivan, A, C Edlund, and CE Nord (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1(2): 101-14.

-Sumanasekera, WK, GU Sumanasekera, KA Mattingly, SM Dougherty, RS Keynton, and CM Klinge (2007) Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity- induced alterations in MAPK activity. Am J Physiol Cell Physiol 293(2): C566-73.

-Summers, RL, DS Martin, JV Meck, and TG Coleman (2005) Mechanism of spaceflight-induced changes in left ventricular mass. Am J Cardiol 95(9): 1128-30.

-Swerdlow, NR, and MA Geyer (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24(2): 285-301.

-Taddeo, T, and C Armstrong (2008). Spaceflight Medical Systems. Principles of Clinical Medicine for Space Flight. M Barratt and S Pool. New York, Springer.

-Takacs, B, and D Hanak (2008) A prototype home robot with an ambient facial interface to improve drug compliance. J Telemed Telecare 14(7): 393-5.

-Tamma, R, G Colaianni, LL Zhu, A DiBenedetto, G Greco, G Montemurro, N Patano, M Strippoli, R Vergari, L Mancini, S Colucci, M Grano, R Faccio, X Liu, J Li, S Usmani, M Bachar, I Bab, K Nishimori, LJ Young, C Buettner, J Iqbal, L Sun, M Zaidi, and A Zallone (2009) Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A 106(17): 7149-54.

-Tan, DX, LC Manchester, MP Terron, LJ Flores, and RJ Reiter (2007) One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42(1): 28-42.

-Taub, DD (2008) Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Horm 77: 325-46.

-Taylor, KH, LS Middlefell, and KD Mizen (2009) Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br J Oral Maxillofac Surg.

-Thompson, DG, AS Mason, and FJ Goodwin (1979) Mineralocorticoid replacement in Addison's disease. Clin Endocrinol (Oxf) 10(5): 499-506.

-Thornton, WE, TP Moore, SL Pool, and J Vanderploeg (1987) Clinical characterization and etiology of space motion sickness. Aviation Space and Environmental Medicine 58(9 Pt 2): A1-8.

-Tischler, ME, EJ Henriksen, KA Munoz, CS Stump, CR Woodman, and CR Kirby (1993) Spaceflight on STS- 48 and earth-based unweighting produce similar effects on skeletal muscle of young rats. J Appl Physiol 74(5): 2161-5.

-Tixador, R, G Richoilley, G Gasset, J Templier, JC Bes, N Moatti, and L Lapchine (1985) Study of minimal inhibitory concentration of antibiotics on bacteria cultivated in vitro in space (Cytos 2 experiment). Aviat Space Environ Med 56(8): 748-51.

-Tobin, BW, PN Uchakin, and SK Leeper-Woodford (2002) Insulin secretion and sensitivity in space flight: diabetogenic effects. Nutrition 18(10): 842-8.

-Tochikubo, O, A Ikeda, E Miyajima, and M Ishii (1996) Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 27(6): 1318-24.

-Treister, N, N Sheehy, EH Bae, B Friedland, M Lerman, and S Woo (2009) Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws. Oral Dis 15(1): 88-92.

-Tricarico, D, A Mele, and D Conte Camerino (2005) Phenotype-dependent functional and pharmacological properties of BK channels in skeletal muscle: effects of microgravity. Neurobiol Dis 20(2): 296-302.

-Tricker, R, R Casaburi, TW Storer, B Clevenger, N Berman, A Shirazi, and S Bhasin (1996) The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men--a clinical research center study. J Clin Endocrinol Metab 81(10): 3754-8.

-Tsuji, K, PD Rahn, and KA Steindler (1983) 60Co-irradiation as an alternate method for sterilization of penicillin G, neomycin, novobiocin, and dihydrostreptomycin. J Pharm Sci 72(1): 23-6.

-Turner, PL, and MA Mainster (2008) Circadian photoreception: ageing and the eye's important role in systemic health. Br J Ophthalmol 92(11): 1439-44.

-Turnheim, K (2003) When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 38(8): 843-53.

-Turnheim, K (2004) Drug therapy in the elderly. Exp Gerontol 39(11-12): 1731-8.

-Urquhart, J, and B Vrijens (2006) 'Hedged' prescribing for partially compliant patients. Clin Pharmacokinet 45(1): 105-8.

-Van Dongen, HP, and DF Dinges (2005) Sleep, circadian rhythms, and psychomotor vigilance. Clin Sports Med 24(2): 237-49, vii-viii.

-Van Dongen, HP, NJ Price, JM Mullington, MP Szuba, SC Kapoor, and DF Dinges (2001) Caffeine eliminates psychomotor vigilance deficits from sleep inertia. Sleep 24(7): 813-9.

-van Oeveren, A, M Motamedi, NS Mani, KB Marschke, FJ Lopez, WT Schrader, A Negro-Vilar, and L Zhi (2006) Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator. J Med Chem 49(21): 6143-6.

-Vecsey, CG, GS Baillie, D Jaganath, R Havekes, A Daniels, M Wimmer, T Huang, KM Brown, XY Li, G Descalzi, SS Kim, T Chen, YZ Shang, M Zhuo, MD Houslay, and T Abel (2009) Sleep deprivation impairs cAMP signalling in the hippocampus. Nature 461(7267): 1122-5.

-Verheyden, B, J Liu, F Beckers, and AE Aubert (2009) Adaptation of heart rate and blood pressure to short and long duration space missions. Respir Physiol Neurobiol 169 Suppl 1: S13-6.

-Vernikos, J, and VA Convertino (1994) Advantages and disadvantages of fludrocortisone or saline load in preventing post-spaceflight orthostatic hypotension. Acta Astronaut 33: 259-66.

-Vernikos, J, MF Dallman, G Van Loon, and LC Keil (1991) Drug effects on orthostatic intolerance induced by bedrest. J Clin Pharmacol 31(10): 974-84.

-Vrijens, B, and J Urquhart (2005) Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother 55(5): 616-27.

-Wade, CE, MM Miller, LA Baer, MM Moran, MK Steele, and TP Stein (2002) Body mass, energy intake, and water consumption of rats and humans during space flight. Nutrition 18(10): 829-36.

-Wade, CE, TJ Wang, KC Lang, BJ Corbin, and MK Steele (2000) Rat growth, body composition, and renal function during 30 days increased ambient CO2 exposure. Aviat Space Environ Med 71(6): 599- 609.

-Walsh, JK, and CL Engelhardt (1992) Trends in the pharmacologic treatment of insomnia. J Clin Psychiatry 53 Suppl: 10-7; discussion 18.

-Walsh, JK, GW Vogel, M Scharf, M Erman, C William Erwin, PK Schweitzer, RM Mangano, and T Roth (2000) A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. Sleep Med 1(1): 41-49.

-Wang, C, G Cunningham, A Dobs, A Iranmanesh, AM Matsumoto, PJ Snyder, T Weber, N Berman, L Hull, and RS Swerdloff (2004) Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89(5): 2085-98.

-Wang, C, RS Swerdloff, A Iranmanesh, A Dobs, PJ Snyder, G Cunningham, AM Matsumoto, T Weber, and N Berman (2000) Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85(8): 2839-53.

-Wang, G, HM Lee, E Englander, and GH Greeley, Jr. (2002) Ghrelin--not just another stomach hormone. Regul Pept 105(2): 75-81.

-Wang, SS, and TA Good (2001) Effect of culture in a rotating wall bioreactor on the physiology of differentiated neuron-like PC12 and SH-SY5Y cells. J Cell Biochem 83(4): 574-84.

-Watanabe, Y, H Ohshima, K Mizuno, C Sekiguchi, M Fukunaga, K Kohri, J Rittweger, D Felsenberg, T Matsumoto, and T Nakamura (2004) Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res 19(11): 1771-8.

-Watenpaugh, DE, SF Vissing, LD Lane, JC Buckey, BG Firth, W Erdman, AR Hargens, and CG Blomqvist (1995) Pharmacologic atrial natriuretic peptide reduces human leg capillary filtration. J Cardiovasc Pharmacol 26(3): 414-9.

-Waters, WW, SH Platts, BM Mitchell, PA Whitson, and JV Meck (2005) Plasma volume restoration with salt tablets and water after bed rest prevents orthostatic hypotension and changes in supine hemodynamic and endocrine variables. Am J Physiol Heart Circ Physiol 288(2): H839-47.

-Waters, WW, MG Ziegler, and JV Meck (2002) Postspaceflight orthostatic hypotension occurs mostly in women and is predicted by low vascular resistance. J Appl Physiol 92(2): 586-94.

-Watt, D, and L Lefebvre (2003) Vestibular suppression during space flight. J Vestib Res 13(4-6): 363-76.

-Webb, WB (1974) Sleep as an adaptive response. Percept Mot Skills 38(3): 1023-7.

-Wesensten, NJ (2006) Effects of modafinil on cognitive performance and alertness during sleep deprivation. Curr Pharm Des 12(20): 2457-71.

-Wesensten, NJ, TJ Balkin, HQ Davis, and GL Belenky (1995) Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil. Psychopharmacology (Berl) 121(2): 242-9.

-West, L (1969). Dream Psychology and the New Biology of Dreaming. Springfield IL, Charles C. Thomas.

-Whitnall, MH, CE Inal, WE Jackson, 3rd, VL Miner, V Villa, and TM Seed (2001) In vivo radioprotection by 5-androstenediol: stimulation of the innate immune system. Radiat Res 156(3): 283-93.

-Whitnall, MH, V Villa, TM Seed, J Benjack, V Miner, ML Lewbart, CA Dowding, and WE Jackson, 3rd (2005) Molecular specificity of 5-androstenediol as a systemic radioprotectant in mice. Immunopharmacol Immunotoxicol 27(1): 15-32.

-Whitson, PA, RA Pietrzyk, JA Jones, M Nelman-Gonzalez, EK Hudson, and CF Sams (2009) Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight. J Urol 182(5): 2490-6.

-Whitson, PA, L Putcha, YM Chen, and E Baker (1995) Melatonin and cortisol assessment of circadian shifts in astronauts before flight. J Pineal Res 18(3): 141-7.

-Wiederhold, ML, JL Harrison, and W Gao (2003) A critical period for gravitational effects on otolith formation. J Vestib Res 13(4-6): 205-14.

-Williamson, JR, NJ Vogler, and C Kilo (1971) Regional variations in the width of the basement membrane of muscle capillaries in man and giraffe. Am J Pathol 63(2): 359-70.

-Wilson, JW, CM Ott, K Honer zu Bentrup, R Ramamurthy, L Quick, S Porwollik, P Cheng, M McClelland, G Tsaprailis, T Radabaugh, A Hunt, D Fernandez, E Richter, M Shah, M Kilcoyne, L Joshi, M Nelman- Gonzalez, S Hing, M Parra, P Dumars, K Norwood, R Bober, J Devich, A Ruggles, C Goulart, M Rupert, L Stodieck, P Stafford, L Catella, MJ Schurr, K Buchanan, L Morici, J McCracken, P Allen, C Baker-Coleman, T Hammond, J Vogel, R Nelson, DL Pierson, HM Stefanyshyn-Piper, and CA Nickerson (2007) Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proc Natl Acad Sci U S A 104(41): 16299-304.

-Wilson, JW, CM Ott, L Quick, R Davis, K Honer zu Bentrup, A Crabbe, E Richter, S Sarker, J Barrila, S Porwollik, P Cheng, M McClelland, G Tsaprailis, T Radabaugh, A Hunt, M Shah, M Nelman- Gonzalez, S Hing, M Parra, P Dumars, K Norwood, R Bober, J Devich, A Ruggles, A CdeBaca, S Narayan, J Benjamin, C Goulart, M Rupert, L Catella, MJ Schurr, K Buchanan, L Morici, J McCracken, MD Porter, DL Pierson, SM Smith, M Mergeay, N Leys, HM Stefanyshyn-Piper, D Gorie, and CA Nickerson (2008) Media ion composition controls regulatory and virulence response of Salmonella in spaceflight. PLoS One 3(12): e3923.

-Wilson, JW, R Ramamurthy, S Porwollik, M McClelland, T Hammond, P Allen, CM Ott, DL Pierson, and CA Nickerson (2002) Microarray analysis identifies Salmonella genes belonging to the low-shear modeled microgravity regulon. Proc Natl Acad Sci U S A 99(21): 13807-12.

-Wimalawansa, SM, and SJ Wimalawansa (1999) Simulated weightlessness-induced attenuation of testosterone production may be responsible for bone loss. Endocrine 10(3): 253-60.

-Wood, CD, and A Graybiel (1968) Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions. Aerosp Med 39(12): 1341-4.

-Wood, CD, JE Manno, BR Manno, RC Odenheimer, and LE Bairnsfather (1986) The effect of antimotion sickness drugs on habituation to motion. Aviat Space Environ Med 57(6): 539-42.

-Wood, CD, JE Manno, BR Manno, HM Redetzki, M Wood, and WA Vekovius (1984) Side effects of antimotion sickness drugs. Aviat Space Environ Med 55(2): 113-6.

-Wood, CD, JJ Stewart, MJ Wood, JE Manno, BR Manno, and ME Mims (1990) Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness. Aviat Space Environ Med 61(2): 157-61.

-Wood, MJ, CD Wood, JE Manno, BR Manno, and HM Redetzki (1987) Nuclear medicine evaluation of motion sickness and medications on gastric emptying time. Aviat Space Environ Med 58(11): 1112-4.

-Woodard, D, G Knox, KJ Myers, W Chelen, and B Ferguson (1993) Phenytoin as a countermeasure for motion sickness in NASA maritime operations. Aviat Space Environ Med 64(5): 363-6.

-Wu, H, J Huff, R Casey, M-H Kim, and FA Cucinotta (2008). Risk of Acute Radiation Syndromes due to Solar Particle Events. H NASA, HHC.

-Xiao, M, and MH Whitnall (2009) Pharmacological countermeasures for the acute radiation syndrome. Curr Mol Pharmacol 2(1): 122-33.

-Xiong, J, Y Li, and J Nie (2003) Effects of simulated microgravity on nitric oxide level in cardiac myocytes and its mechanism. Sci China C Life Sci 46(3): 302-9.

-Yamaguchi, M, K Ozaki, and T Hoshi (1991) Simulated weightlessness and bone metabolism: impairment of glucose consumption in bone tissue. Res Exp Med (Berl) 191(2): 105-11.

-Yates, BJ, and AD Miller (1998) Physiological evidence that the vestibular system participates in autonomic and respiratory control. J Vestib Res 8(1): 17-25.

-Yates, BJ, AD Miller, and JB Lucot (1998) Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 47(5): 395-406.

-Yegorov, AD, LI Kakurin, and YG Nefyodov (1972) Effects of an 18-day flight on the human body. Life Sci Space Res 10: 57-60.

-Zachwieja, JJ, SR Smith, JC Lovejoy, JC Rood, MM Windhauser, and GA Bray (1999) Testosterone administration preserves protein balance but not muscle strength during 28 days of bed rest. J Clin Endocrinol Metab 84(1): 207-12.

-Zammit, GK, B Corser, K Doghramji, JM Fry, S James, A Krystal, and RM Mangano (2006) Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening. J Clin Sleep Med 2(4): 417-23.

-Zerwekh, JE, CV Odvina, LA Wuermser, and CY Pak (2007) Reduction of renal stone risk by potassium- magnesium citrate during 5 weeks of bed rest. J Urol 177(6): 2179-84.

-Zhi, JG, and G Levy (1989) Kinetics of drug action in disease states. XXXVII. Effects of acute fluid overload and water deprivation on the hypnotic activity of phenobarbital and the neurotoxicity of theophylline in rats. J Pharmacol Exp Ther 251(3): 827-32.

-Zhou, Y, and MT Mi (2005) Genistein stimulates hematopoiesis and increases survival in irradiated mice. J Radiat Res (Tokyo) 46(4): 425-33.

-Zwart, SR, JE Davis-Street, D Paddon-Jones, AA Ferrando, RR Wolfe, and SM Smith (2005) Amino acid supplementation alters bone metabolism during simulated weightlessness. J Appl Physiol 99(1): 134-40.

-Zwart, SR, AR Hargens, and SM Smith (2004) The ratio of animal protein intake to potassium intake is a predictor of bone resorption in space flight analogues and in ambulatory subjects. Am J Clin Nutr 80(4): 1058-65.

-Zwart, SR, D Pierson, S Mehta, S Gonda, and SM Smith (2009) Capacity of Omega-3 Fatty Acids or Eicosapentaenoic Acid to Counteract Weightlessness-Induced Bone Loss by Inhibiting NF-kappaB Activation: From Cells to Bed Rest to Astronauts. J Bone Miner Res.